Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp von Hundelshausen

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Cancers|April 3, 2021
Bleeding by Bruton Tyrosine Kinase-Inhibitors: Dependency on Drug Type and DiseasePhilipp von Hundelshausen, Wolfgang Siess
Circulation Research|January 6, 2007
Platelets as immune cells: bridging inflammation and cardiovascular diseasePhilipp von Hundelshausen, Christian Weber
Frontiers in Immunology|November 13, 2023
Chemokines, molecular drivers of thromboinflammation and immunothrombosisJulian Leberzammer, Philipp von Hundelshausen
Thrombosis and Haemostasis|August 11, 2020
Novel Approaches to Fine-Tune Therapeutic Targeting of Platelets in Atherosclerosis: A Critical AppraisalThorsten Kessler, Heribert Schunkert, Philipp von Hundelshausen
Thrombosis and Haemostasis|May 5, 2007
Platelet-derived chemokines in vascular biologyPhilipp von Hundelshausen, Frank Petersen, Ernst Brandt
Thrombosis and Haemostasis|July 3, 2019
Glycans and Glycan-Binding Proteins in AtherosclerosisVeit Eckardt, Christian Weber, Philipp von Hundelshausen
Frontiers in Physiology|August 26, 2014
Platelets and their chemokines in atherosclerosis-clinical applicationsPhilipp von Hundelshausen, Martin M N Schmitt
International Journal of Molecular Sciences|July 14, 2023
Chemokine Heteromers and Their Impact on Cellular Function-A Conceptual FrameworkXavier Blanchet, Christian Weber, Philipp von Hundelshausen
Thrombosis and Haemostasis|July 8, 2026
Bruton Tyrosine Kinase as Therapeutic Target in Cardiovascular Diseases-Executive SummaryPhilipp von Hundelshausen, Wolfgang Siess, Christian Weber
Arteriosclerosis, Thrombosis, and Vascular Biology|August 30, 2008
Platelet chemokines in vascular diseaseChristian A Gleissner, Philipp von Hundelshausen, Klaus Ley
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Cancers|April 3, 2021
Bleeding by Bruton Tyrosine Kinase-Inhibitors: Dependency on Drug Type and DiseasePhilipp von Hundelshausen, Wolfgang Siess
Circulation Research|January 6, 2007
Platelets as immune cells: bridging inflammation and cardiovascular diseasePhilipp von Hundelshausen, Christian Weber
Frontiers in Immunology|November 13, 2023
Chemokines, molecular drivers of thromboinflammation and immunothrombosisJulian Leberzammer, Philipp von Hundelshausen
Thrombosis and Haemostasis|August 11, 2020
Novel Approaches to Fine-Tune Therapeutic Targeting of Platelets in Atherosclerosis: A Critical AppraisalThorsten Kessler, Heribert Schunkert, Philipp von Hundelshausen
Thrombosis and Haemostasis|May 5, 2007
Platelet-derived chemokines in vascular biologyPhilipp von Hundelshausen, Frank Petersen, Ernst Brandt
Thrombosis and Haemostasis|July 3, 2019
Glycans and Glycan-Binding Proteins in AtherosclerosisVeit Eckardt, Christian Weber, Philipp von Hundelshausen
Frontiers in Physiology|August 26, 2014
Platelets and their chemokines in atherosclerosis-clinical applicationsPhilipp von Hundelshausen, Martin M N Schmitt
International Journal of Molecular Sciences|July 14, 2023
Chemokine Heteromers and Their Impact on Cellular Function-A Conceptual FrameworkXavier Blanchet, Christian Weber, Philipp von Hundelshausen
Thrombosis and Haemostasis|July 8, 2026
Bruton Tyrosine Kinase as Therapeutic Target in Cardiovascular Diseases-Executive SummaryPhilipp von Hundelshausen, Wolfgang Siess, Christian Weber
Arteriosclerosis, Thrombosis, and Vascular Biology|August 30, 2008
Platelet chemokines in vascular diseaseChristian A Gleissner, Philipp von Hundelshausen, Klaus Ley
Pageof 6